Personal information

Emails & domains

Verified email addresses

Verified email domains

Other IDs

Scopus Author ID: 8501683300
Loop profile: 190917
ResearcherID: AAL-3693-2021

Keywords

Immunology, Neuro-Oncology, Immunotherapy

Countries

Italy

Activities

Collapse all

Employment (6)

Fondazione IRCCS Istituto Neurologico Carlo Besta: Milano, Lombardia, IT

2018-04-16 to present | Head (Immunotherapy of Brain Tumors)
Employment
Source: Self-asserted source
Serena Pellegatta

Fondazione IRCCS Istituto Neurologico Carlo Besta: Milano, Lombardia, IT

2010-04-01 to 2018-04-16 | Team Leader (Molecular Neuro-Oncology)
Employment
Source: Self-asserted source
Serena Pellegatta

Fondazione IRCCS Istituto Neurologico Carlo Besta: Milano, Lombardia, IT

2008-11-21 to 2010-03-30 | Senior Scientist (Molecular Neuro-Oncology)
Employment
Source: Self-asserted source
Serena Pellegatta

Fondazione IRCCS Istituto Neurologico Carlo Besta: Milano, Lombardia, IT

2005-11-20 to 2008-11-20 | PhD Student
Employment
Source: Self-asserted source
Serena Pellegatta

Fondazione IRCCS Istituto Neurologico Carlo Besta: Milano, Lombardia, IT

2002-01-02 to 2005-07-12 | Research Fellow (specialization student) (Neuro-Oncology and Gene Therapy)
Employment
Source: Self-asserted source
Serena Pellegatta

Fondazione IRCCS Istituto Nazionale dei Tumori: Milano, Lombardia, IT

2000-01-02 to 2001-12-16 | Research fellow (Unit of Immunobiology of human tumors)
Employment
Source: Self-asserted source
Serena Pellegatta

Education and qualifications (3)

Universita degli Studi di Milano-Bicocca: Milano, Lombardia, IT

2005-11-20 to 2008-11-21 | PhD (Molecular and Translational Medicine)
Qualification
Source: Self-asserted source
Serena Pellegatta

Università degli Studi di Milano: Milano, Lombardia, IT

2002-11-20 to 2005-07-12 (Biothecnology Application)
Education
Source: Self-asserted source
Serena Pellegatta

Università degli Studi di Milano: Milano, Lombardia, IT

1994-11-30 to 1999-12-16 | Biology (physiopathology and immunopharmacology)
Education
Source: Self-asserted source
Serena Pellegatta

Professional activities (2)

UNC Health Care System: Chapel Hill, NC, US

2015-07-01 to 2016-06-30 | Visiting Professor (Microbiology and Immunology)
Invited position
Source: Self-asserted source
Serena Pellegatta

IFOM-IEO Campus: Milano, Lombardia, IT

2008-09-08 to 2014-02-24 | Senior Scientist (Experimental Oncology)
Invited position
Source: Self-asserted source
Serena Pellegatta

Peer review (23 reviews for 13 publications/grants)

Review activity for Biomedicines. (1)
Review activity for Cancers. (3)
Review activity for Communications biology. (1)
Review activity for Expert review of anticancer therapy (2)
Review activity for International journal of molecular sciences. (2)
Review activity for Journal for immunotherapy of cancer. (4)
Review activity for Journal of the National Cancer Institute (1)
Review activity for Journal of the National Cancer Institute : (1)
Review activity for Nature communications (2)
Review activity for Neuro-oncology. (3)
Review activity for Neurological sciences. (1)
Review activity for Pharmaceutics. (1)
Review activity for Signal transduction and targeted therapy. (1)
How many people are using ORCID?